Login / Signup

Experience of conducting clinical trials of investigational medicinal products during a respiratory virus pandemic: Lessons learnt from COVID-19.

James E BurnsFfion E Carlin
Published in: Clinical trials (London, England) (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • clinical trial
  • phase ii
  • respiratory syndrome coronavirus
  • open label
  • study protocol
  • double blind
  • randomized controlled trial